Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses

PurposeInjection of an antigen into the anterior chamber of the eye induces a peripheral antigen-specific immune modulation mechanism, known as anterior chamber-associated immune deviation (ACAID). Delayed-type hypersensitivity experiments argue that the subretinal space (SR) of the eye displays pro...

Full description

Bibliographic Details
Main Authors: Julie Vendomèle, Safa Dehmani, Quentin Khebizi, Anne Galy, Sylvain Fisson
Format: Article
Language:English
Published: Frontiers Media S.A. 2018-03-01
Series:Frontiers in Immunology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fimmu.2018.00504/full
_version_ 1819030764297125888
author Julie Vendomèle
Safa Dehmani
Quentin Khebizi
Anne Galy
Sylvain Fisson
author_facet Julie Vendomèle
Safa Dehmani
Quentin Khebizi
Anne Galy
Sylvain Fisson
author_sort Julie Vendomèle
collection DOAJ
description PurposeInjection of an antigen into the anterior chamber of the eye induces a peripheral antigen-specific immune modulation mechanism, known as anterior chamber-associated immune deviation (ACAID). Delayed-type hypersensitivity experiments argue that the subretinal space (SR) of the eye displays properties similar to ACAID. However, no investigation was performed regarding the differential impact of a subretinal antigen injection on peripheral CD4+ versus CD8+ T cells, on the potential immune deviation regarding Th profiles, and on the antigen-specificity of the inhibition. A better understanding of these mechanisms is crucial to improve safety and immunomonitoring of ongoing therapeutic approaches targeting the SR. The aim of this study is to characterize the proliferative capacities and cytokine patterns of antigen-specific CD4+ and CD8+ T cells after a subretinal injection of antigen in mice.MethodsUbiquitously Transcribed tetratricopeptide repeat gene Y-linked (UTY) and DEAD Box polypeptide 3 Y-linked (DBY) peptides which respectively include MHCI- and MHCII-restricted T-cell epitopes of the mouse HY male antigen, were injected into the subretinal space of C57BL/6 female mice. 2 weeks later, these mice were immunized subcutaneously with these peptides and compared to control mice. A week later, T-cell immune responses were analyzed by IFNγ ELISpot assays and cytokine measurements (IL-2, IL-4, IL-6, IL-10, IL-13, IL-17a, IFNγ, TNFα, GM-CSF, and MCP-1) in the spleen and with proliferation assays in draining lymph nodes.ResultsImmune cells from mice that received HY peptides in the SR before immunization, compared with those from control immunized mice, secreted significantly smaller quantities of Th1/Tc1, Th2/Tc2, and Th17/Tc17 cytokines, and HY-specific CD4+ T cells proliferated less in response to HY peptides.ConclusionTaken together, our data clearly demonstrate that the subretinal injection of HY peptides induces a systemic HY-specific inhibition of conventional Th profiles and CD8+ T cells. We propose to call this phenomenon SRAII, for subretinal-associated immune inhibition.
first_indexed 2024-12-21T06:35:20Z
format Article
id doaj.art-b0f9413c9ac843eb9a4fb74dbc8d4bb8
institution Directory Open Access Journal
issn 1664-3224
language English
last_indexed 2024-12-21T06:35:20Z
publishDate 2018-03-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Immunology
spelling doaj.art-b0f9413c9ac843eb9a4fb74dbc8d4bb82022-12-21T19:12:54ZengFrontiers Media S.A.Frontiers in Immunology1664-32242018-03-01910.3389/fimmu.2018.00504332246Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell ResponsesJulie Vendomèle0Safa Dehmani1Quentin Khebizi2Anne Galy3Sylvain Fisson4Généthon, Inserm UMR_S951, Univ Evry, Université Paris Saclay, EPHE, Evry, FranceGénéthon, Inserm UMR_S951, Univ Evry, Université Paris Saclay, EPHE, Evry, FranceGénéthon, Inserm UMR_S951, Univ Evry, Université Paris Saclay, EPHE, Evry, FranceGénéthon, Inserm UMR_S951, Univ Evry, Université Paris Saclay, EPHE, Evry, FranceGénéthon, Inserm UMR_S951, Univ Evry, Université Paris Saclay, EPHE, Evry, FrancePurposeInjection of an antigen into the anterior chamber of the eye induces a peripheral antigen-specific immune modulation mechanism, known as anterior chamber-associated immune deviation (ACAID). Delayed-type hypersensitivity experiments argue that the subretinal space (SR) of the eye displays properties similar to ACAID. However, no investigation was performed regarding the differential impact of a subretinal antigen injection on peripheral CD4+ versus CD8+ T cells, on the potential immune deviation regarding Th profiles, and on the antigen-specificity of the inhibition. A better understanding of these mechanisms is crucial to improve safety and immunomonitoring of ongoing therapeutic approaches targeting the SR. The aim of this study is to characterize the proliferative capacities and cytokine patterns of antigen-specific CD4+ and CD8+ T cells after a subretinal injection of antigen in mice.MethodsUbiquitously Transcribed tetratricopeptide repeat gene Y-linked (UTY) and DEAD Box polypeptide 3 Y-linked (DBY) peptides which respectively include MHCI- and MHCII-restricted T-cell epitopes of the mouse HY male antigen, were injected into the subretinal space of C57BL/6 female mice. 2 weeks later, these mice were immunized subcutaneously with these peptides and compared to control mice. A week later, T-cell immune responses were analyzed by IFNγ ELISpot assays and cytokine measurements (IL-2, IL-4, IL-6, IL-10, IL-13, IL-17a, IFNγ, TNFα, GM-CSF, and MCP-1) in the spleen and with proliferation assays in draining lymph nodes.ResultsImmune cells from mice that received HY peptides in the SR before immunization, compared with those from control immunized mice, secreted significantly smaller quantities of Th1/Tc1, Th2/Tc2, and Th17/Tc17 cytokines, and HY-specific CD4+ T cells proliferated less in response to HY peptides.ConclusionTaken together, our data clearly demonstrate that the subretinal injection of HY peptides induces a systemic HY-specific inhibition of conventional Th profiles and CD8+ T cells. We propose to call this phenomenon SRAII, for subretinal-associated immune inhibition.http://journal.frontiersin.org/article/10.3389/fimmu.2018.00504/fullanterior chamber-associated immune deviationeyeocular immune privilegesubretinal-associated immune inhibitionT-cells
spellingShingle Julie Vendomèle
Safa Dehmani
Quentin Khebizi
Anne Galy
Sylvain Fisson
Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses
Frontiers in Immunology
anterior chamber-associated immune deviation
eye
ocular immune privilege
subretinal-associated immune inhibition
T-cells
title Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses
title_full Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses
title_fullStr Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses
title_full_unstemmed Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses
title_short Subretinal Injection of HY Peptides Induces Systemic Antigen-Specific Inhibition of Effector CD4+ and CD8+ T-Cell Responses
title_sort subretinal injection of hy peptides induces systemic antigen specific inhibition of effector cd4 and cd8 t cell responses
topic anterior chamber-associated immune deviation
eye
ocular immune privilege
subretinal-associated immune inhibition
T-cells
url http://journal.frontiersin.org/article/10.3389/fimmu.2018.00504/full
work_keys_str_mv AT julievendomele subretinalinjectionofhypeptidesinducessystemicantigenspecificinhibitionofeffectorcd4andcd8tcellresponses
AT safadehmani subretinalinjectionofhypeptidesinducessystemicantigenspecificinhibitionofeffectorcd4andcd8tcellresponses
AT quentinkhebizi subretinalinjectionofhypeptidesinducessystemicantigenspecificinhibitionofeffectorcd4andcd8tcellresponses
AT annegaly subretinalinjectionofhypeptidesinducessystemicantigenspecificinhibitionofeffectorcd4andcd8tcellresponses
AT sylvainfisson subretinalinjectionofhypeptidesinducessystemicantigenspecificinhibitionofeffectorcd4andcd8tcellresponses